Impact of rheumatoid arthritis and methotrexate on pregnancy outcomes: retrospective cohort study of the Italian Society for Rheumatology.
Anna ZanettiAntonella ZambonAnd Carlo Alberto ScirèAlessandra BortoluzziPublished in: RMD open (2023)
MTX-treated patients appeared to be the cohort with the highest risk of pregnancy losses. The positive association with elective TOP and exposure to MTX in the three months window before conception in patients with RA reinforces the need for adequate preconception counselling to avoid unplanned pregnancies.
Keyphrases
- pregnancy outcomes
- rheumatoid arthritis
- pregnant women
- newly diagnosed
- end stage renal disease
- preterm birth
- ejection fraction
- disease activity
- prognostic factors
- high dose
- patients undergoing
- interstitial lung disease
- systemic lupus erythematosus
- patient reported outcomes
- low dose
- hepatitis c virus
- gestational age
- patient reported